TrialJapanese journal of clinical oncology2022

Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.

Toshikazu Moriwaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.